Skip to main content

Table 1 Suggested medicines to be included in the WHO EML

From: Revising the WHO Essential Medicines List for paediatric rheumatology

Drug Should Include (Ideal) (% refers to respondents) Inclusion ‘Essential’
Oral prednisolone 100% 92%
Oral NSAIDs 99% 93%
Hydroxychloroquine 98% 88%
Intravenous Methylprednisolone 98% 83%
Methotrexate oral 96% 81%
Mycophenolate Mofetil 95% 77%
Azathioprine 94% 71%
Methotrexate subcutaneous 91% 80%
Intravenous cyclophosphamide 91% 77%
Adalimumab 91% 71%
Anakinra 90% 60%
Etanercept 87% 70%
Intra-articular corticosteroid Triamcinolone Hexacetonide 86% 64%
Intravenous Tocilizumab 86% 63%
Oral prednisolone (soluble) 86% 55%
Ciclosporin 85% 52%
Sulphasalazine 84% 51%
Subcutaneous Tocilizumab 81% 46%
Infliximab 80% 52%
Intravenous bisphosphonate (e.g. pamidronate) 76% 37%
Intra-articular corticosteroid Triamcinolone Acetonide 72% 28%
Intra-articular corticosteroid Methylprednisolone 45% 25%
Oral cyclophosphamide 41% 16%
Inhaled analgesia (nitrous oxide) 36% 15%
Thalidomide 34% 8%
Total Respondents: 97